Access the full text.
Sign up today, get DeepDyve free for 14 days.
J Bradwejn, D Koszycki (1994)
Imipramine antagonizes the panicogenic effects of CCK‐4 in panic disorder patients, 151
L. Kruglyak, M. Daly, Mary Reeve-Daly, E. Lander (1996)
Parametric and nonparametric linkage analysis: a unified multipoint approach.American journal of human genetics, 58 6
Raymond Crowe, Russell Noyes, Alexander Wilson, R. Elston, L. Ward (1987)
A linkage study of panic disorder.Archives of general psychiatry, 44 11
G. Lathrop, J. Lalouel (1984)
Easy calculations of lod scores and genetic risks on small computers.American journal of human genetics, 36 2
Yohsuke Takahashi, S. Fukushige, T. Murotsu, K. Matsubara (1986)
Structure of human cholecystokinin gene and its chromosomal location.Gene, 50 1-3
F. Nielsen, K. Pedersen, T. Hansen, I. Rourke, J. Rehfeld (1996)
Transcriptional regulation of the human cholecystokinin gene: composite action of upstream stimulatory factor, Sp1, and members of the CREB/ATF-AP-1 family of transcription factors.DNA and cell biology, 15 1
W. Eaton, R. Kessler, H. Wittchen, W. Magee (1994)
Panic and panic disorder in the United States.The American journal of psychiatry, 151 3
W. Solinge, J. Rehfeld (1992)
Co‐transcription of the gastrin and cholecystokinin genes with selective translation of gastrin mRNA in a human gastric carcinoma cell lineFEBS Letters, 309
S.M. Schmidt, T. Zoëga, R. Crowe (1993)
Excluding linkage between panic disorder and the gamma‐aminobutyric acid beta 1 receptor locus in five Icelandic pedigreesActa Psychiatrica Scandinavica, 88
Myrna Weissman, P. Wickramaratne, P. Adams, J. Lish, E. Horwath, Dennis Charney, Scott Woods, Eve Leeman, Emily Frosch (1993)
The relationship between panic disorder and major depression. A new family study.Archives of general psychiatry, 50 10
N. Risch (1988)
A new statistical test for linkage heterogeneity.American journal of human genetics, 42 2
R. Kessler, K. Mcgonagle, Shanyang Zhao, C. Nelson, M. Hughes, S. Eshleman, H. Wittchen, K. Kendler (1994)
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.Archives of general psychiatry, 51 1
PA Di Nardo, K Moras, DH Barlow, RM Rapee, TA Brown (1993)
Reliability of the DSM‐III‐R anxiety disorder categories using the Anxiety Disorders Interview Schedule‐Revised (ADIS‐R), 46
K. Kendler, M. Neale, R. Kessler, A. Heath, L. Eaves (1993)
Panic disorder in women: a population-based twin studyPsychological Medicine, 23
D. Sheehan, K. Sheehan, W. Minichiello (1981)
Age of onset of phobic disorders: a reevaluation.Comprehensive psychiatry, 22 6
F. Pitts, J. McClure (1967)
Lactate metabolism in anxiety neurosis.The New England journal of medicine, 277 25
D. Greenberg (1993)
Linkage analysis of "necessary" disease loci versus "susceptibility" loci.American journal of human genetics, 52 1
R. Shiang, A. Lidral, H. Ardinger, H. Ardinger, K. Buetow, P. Romitti, R. Munger, J. Murray (1993)
Association of transforming growth-factor alpha gene polymorphisms with nonsyndromic cleft palate only (CPO).American journal of human genetics, 53 4
J. Crawley, R. Corwin (1994)
Biological actions of cholecystokininPeptides, 15
J. Berkson (1946)
Limitations of the application of fourfold table analysis to hospital data.Biometrics, 2 3
J. Gorman, Papp La, J. Coplan, Jose Martinez, S. Lennon, R. Goetz, D. Ross, D. Klein (1994)
Anxiogenic effects of CO2 and hyperventilation in patients with panic disorder.The American journal of psychiatry, 151 4
Lydiard Rb, Ballenger Jc, Laraia Mt, Fossey, M. Beinfeld (1992)
CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects.The American journal of psychiatry, 149 5
S. Torgersen (1983)
Genetic factors in anxiety disorders.Archives of general psychiatry, 40 10
D. Charney, S. Woods, W. Goodman, G. Heninger (1987)
Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.The American journal of psychiatry, 144 8
R. Crowe, R. Noyes, D. Pauls, D. Slymen (1983)
A family study of panic disorder.Archives of general psychiatry, 40 10
S. Woods, D. Charney, J. Loke, W. Goodman, D. Redmond, G. Heninger (1986)
Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment.Archives of general psychiatry, 43 9
C. Montigny (1989)
Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.Archives of General Psychiatry, 46
J. Bradwejn, D. Koszycki (1994)
Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients.The American journal of psychiatry, 151 2
J. Bradwejn, D. Koszycki, Christian Shriqui (1991)
Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.Archives of general psychiatry, 48 7
R. Haun, J. Dixon (1990)
A transcriptional enhancer essential for the expression of the rat cholecystokinin gene contains a sequence identical to the -296 element of the human c-fos gene.The Journal of biological chemistry, 265 26
JT Kadonaga, KA Jones, R Tjian (1986)
Promotor‐specific activation of RNA polymerase II transcription by Sp 1, 11
R. Spielman, R. McGinnis, Warren Ewenst (1993)
Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).American journal of human genetics, 52 3
R. Spitzer, Janet Williams, M. Gibbon, M. First (1992)
The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.Archives of general psychiatry, 49 8
(1994)
Diagnostic and Statistical Manual of Mental Disorders
We searched for mutations in the CCK gene in panic disorder with single‐strand conformational polymorphism (SSCP) analysis of the three exons and promotor region of the gene. We found a C→T transition at position −36 (CCK−36C→T) in a GC box, a binding site for transcription factor Sp1, in the promotor region. The allele frequency was 0.168 (95% CI, 0.116–0.221) in 98 persons with panic disorder and 0.083 (95% CI, 0.059–0.107) in 247 geographically matched, unscreened controls. A transmission disequilibrium test based on panic disorder as the affected phenotype was nonsignificant (X2 = 0.93), but when panic disorder or attacks were considered as affected, statistically significant transmission disequilibrium was detected (X2 = 4.00, P < 0.05). Linkage analysis was uninformative. In exploratory analyses to search for clinical correlations, the “T” allele was found in 59% of 22 persons with panic attacks but not panic disorder, compared with 31% of those who met the criteria for panic disorder. An association between the CCK polymorphism and panic disorder cannot be considered established due to the inconsistencies in the results noted above, but if the provisional association can be replicated, the findings are consistent with CCK−36C→T being a disease‐susceptibility allele that alone is neither necessary nor sufficient to cause panic disorder but that increases vulnerability by acting epistatically. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 81:228–234, 1998. © 1998 Wiley‐Liss, Inc.
American Journal of Medical Genetics Part A – Wiley
Published: Aug 8, 1998
Keywords: ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.